Non Small Cell Lung Cancer clinical trials
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 3
- Phase
- Phase 1
- Phase
- Phase 2
- Phase
- Phase 3
- Phase
- Phase 1
- Phase
- Phase 3
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 3
- Phase
- Phase 1
- Phase
- Phase 3
Access comprehensive clinical trial information for Non Small Cell Lung Cancer through Pure Global AI's free database. This collection includes 564 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 113 trials are actively recruiting participants.
Research for Non Small Cell Lung Cancer is being conducted in China, United States of America, France and 7+ other countries. Leading sponsors include Eli Lilly and Company and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 564 clinical trials studying Non Small Cell Lung Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Eli Lilly and Company, AstraZeneca, Hunan Province Tumor Hospital, among others.